[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1624 Introduced in House (IH)]







107th CONGRESS
  1st Session
                                H. R. 1624

To amend title XVIII of the Social Security Act to provide for coverage 
        under the Medicare Program of all oral anticancer drugs.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 26, 2001

Ms. Pryce of Ohio (for herself, Mr. Hobson, Mr. Foley, Mrs. Capps, Mr. 
Blunt, Mr. Hall of Ohio, Mrs. Myrick, Mr. Snyder, Mr. Ehrlich, and Mr. 
   Bentsen) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
To amend title XVIII of the Social Security Act to provide for coverage 
        under the Medicare Program of all oral anticancer drugs.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Access to Cancer Therapies Act of 
2001''.

SEC. 2. MEDICARE COVERAGE OF ALL ANTICANCER ORAL DRUGS.

    (a) In General.--Section 1861(s)(2)(Q) of the Social Security Act 
(42 U.S.C. 1395x(s)(2)(Q)) is amended by striking ``chemotherapeutic 
agent for a given indication,'' and all that follows and inserting 
``agent for a medically accepted indication (as defined in subsection 
(t)(2)(B));''.
    (b) Conforming Amendment.--Section 1834(j)(5)(F)(iv) of such Act 
(42 U.S.C. 1395m(j)(5)(F)(iv)) is amended by striking ``therapeutic''.
    (c) Effective Date.--The amendments made by this section shall 
apply with respect to drugs furnished on or after the date that is 90 
days after the date of the enactment of this Act.
                                 <all>